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CHAPTER I
INTRODUCTION
Langerhans cells are dendritic nonkeratinocytes apparently unrelated to melanocytes, which were first described in skin over one hundred
years ago.

They were then thought to represent a fixed population of

peripheral nervous elements in the suprabasal layers of the epidermis
(Langerhans, 1868).

Recent studies have demonstrated lymphocyte-Langer-

hans cell interactions at sites of contact allergic reactions (Silberberg-Sinakin, 1978), and migration of Langerhans cells via dermal lymphatics to lymph nodes {Silberberg, 1975).

Langerhans cells have been shown

to possess on their cell surfaces receptors for

c3 and

Fe- IgG (Stingl,

1977), !a-like antigens (Rowden, 1980), and have been demonstrated capable of presenting antigens to T lymphocytes (Braathen, 1980).

The vast

majority of scientific research concerning Langerhans cells has appeared
in the dermatology literature.

The purpose of this study is 1) to qual-

itatively compare four recent techniques of Langerhans cell detection in
oral epithelium, 2) to quantitatively compare Langerhans cells in clinically normal and clinically inflamed human gingival biopsies.
Subjects will be selected who present with chronic periodontitis
and display moderate to severe gingival inflammation as assessed by the
G.I. of Loe (1967).

A sextant associated with clinically inflamed tis-

sues will not be treated while the remaining teeth will be scaled and
1

2

root planed.

Two gingival biopsies will be taken; clinically normal

treated, and clinically inflamed untreated tissue.
cannot be identified by H&E stained sections.

Langerhans cells

Histochemical and immuno-

cytochemical methods must be utilized under light microscopy.

In the

present study Langerhans cells will be specifically stained for ATPase
(Wachstein and Meisel, 1957), HLA-DR (Rowden, 1977), S-100 (Cocchia et
al; 1981), and OKT6 (Murphy, 1982).

CHAPTER II
LITERATURE REVIEH
A. Studies in Dermatology
In the mid 19th century, Paul Langerhans, while studying the nervous
system, discovered a population of dendritic cells in the epidermis.

He

described them as 11 dark bodies which are very distinct from epithelial
cells .. (Langerhans, 1868).

He visualized these cells by impregnating

human skin with gold salts, observed a suprabasal location, and noted
that some dendrites reached upwards toward the stratum corneum, while
others extended downward through the lower layers of the epidermis.

Lan-

gerhans, however, felt that these cells were part of the nervous sytesm
and that their dendrites reached into the dermis and connected with the
nerve system there.

His theory was maintained until the 1960's (Ferreira-

Marques, 1951; Niebauer &Sekido, 1965).

During the 1950's and 1960's a

concept which postulated a relationship between Langerhans cells and
melanocytes predominated.

Langerhans cells were then regarded as either

previously active melanocytes (Masson, 1951), daughter cells of dividing melanocytes (Zelickson, 1966), or as melanocytes in an arrested stage
of development (Breathnach, 1963).
Although Langerhans cells were first described more than one hundred
years ago, they had failed to attract much attention until the 1960's.
This may have been due, in part, to the technical difficulty of the

3
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available staining techniques and to limitations of experimental methods
to study their biologic activities. The concepts which prevailed to this
time seemed justified and discouraged experiments to search for alternatives.

As investigative procedures improved and the older concepts con-

cerning this cell were challenged, general interest was revived.
The research of the late 1960's and 1970's pointed to a mesenchymal
origin for the Langerhans cell.

Langerhans cell granules (Birbeck gran-

ules) were reported to be present in certain mesodermal tissues (Kondo,
1969) (Hoshimo, 1970) (Breathnach, 1977).

Langerhans cell granules were

also identified in certain histocytic cells of histocytosis X, (Basset &
Turiaf, 1965) (Cancilla:et al ., 1967) malignant cells of malignant histocytosis, (Inamura, 1971) and leukemic reticuloendotheliosis (Shamoto, 1976).
Some investigators postulated that the Langerhans cell might play a
role in immunologic reactions and suggested that the cells might capture
antigenic material.

Hashimoto (1968) considered it to be an epidermal

macrophage. When tracers such as peroxidase are injected in vivo into
the skin some of the material is engulfed by Langerhans cells which incorporate this into their phagolysosomal system {Wolff, 1970). However,
this research also demonstrated that keratinocytes phagocytose with much
more vigor than the "moderately phagocytic" Langerhans cell.

Phagocyto-

sis did not seem to be the major function of the Langerhans cell.
Silberberg (1973) investigated and compared the penetration of mercury in normal skin and in skin of individuals who were contact-allergic
to mercury. She observed close apposition of lymphocytes to Langerhans
cells at sites of contact allergic reactions while in normal skin and

5

irritant reactions there was no apposition.

In a subsequent study in-

volving guinea pigs actively sensitized with 2-4-dinitro-1-chlorobenzene
(DNBC) as opposed to control animals showed lymphocyte-Langerhans cell
apposition as early as 3-5 hours after antigenic challenge.

Langerhans

cells were reduced in number nineteen hours after this antigenic challenge
and seemed to be damaged.
site of antigenic
not only in the

In the passively sensitized guinea pigs at the

challenge~

epidermis~

lymphocyte-Langerhans apposition was seen

but was also pronounced in the dermis where

the Langerhans cells had increased significantly as compared to controls.
Langerhans cells were first seen in the passively sensitized animals two
hours after antigenic challenge.
The findings suggested that the epidermal Langerhans cell system is
the body's first line of defense.
tect against environmental agents

This cell system is well suited to prosince~

under normal

conditions~

molecules

of low molecular weight are the only ones able to penetrate the skin. They
also suggested that Langerhans cells capture antigenic substances in
circulate to a draining lymph

node~

skin~

and cause specific sensitization of

immunocompetent T cells in the node and thus they may play an important
role in delayed-type hypersensitivity reactions. (Silberberg et al.;l976)
Simultaneous publications by Rowden (1977) and Klareskog (1976)
demonstrated that Langerhans cells were the only cell type in humnn epidermis to express !a-like antigens.which were shown to represent HLA-DR.
The investigators used immunofluorescence staining in their experiments.
Ia antigen have been demonstrated to be integral for macrophage antigenpresenting functions (Rosenthal 1978). Langerhans cells from guinea pig
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epidermis were subsequently shown to act in vitro to present exogenous
antigens to sensitized lymphocytes and also act as stimulator cells for
mixed lymphocyte reactions. (Stingl, 1978) Shelley and Juhlin (1976)
demonstrated the ability of Langerhans cells to take up contact allergens
and proposed an antigen-trapping cell system.
At approximately the same time, Stingl et al., (1977) concluded
from his studies that Langerhans cells are the only epidermal cells which
express receptors for c3 and the Fe portion of IgG. It is very unlikely
that Langerhans cells belong to either T or B cell lineage because they
lack the classical cell markers (E receptors and surface immunoglobulins)
which are expressed on the majority of human (Maretta et al.; 1976) and
guinea pig (Stingl et al.;) T and B lymphocytes (Pichler et al.; 1978).
The surface markers present (Fc-IgG and c3 ) correspond to those of macro·
phages, monocytes, and histiocytic cell types i.e. mononuclear phagocytes.
Recent studies by Tamaki and Katz (1979,1980) have utilized the
Langerhans cell property of bearing Ia antigens on their surfaces. These
chimeric studies indicated that Langerhans cells were derived from a continuously replenished mobile pool of precursor cells which originate
mostly from a bone-marrow derived cell line.
There are many important implications to the recognition of Langerhans cells as epidermal macrophages.

The Langerhans cell may be the

major cell responsible for rejection of allografts in the epidermis.
Present research suggests that the Langerhans cells are immunocompetent
cells and function as part of the body's peripheral immune system. They
are especially important in presentation of surface applied antigens to

7

T lymphocytes and stimulation of a subsequent immune response. These
cells seem to have a number·of common features with cells in the monocytemacrophage series.
B. Studies in Oral Mucosa
The oral epithelium as well as the epidermis is composed predominantly of keratinocytes. There is also, however, a minority population
of non-keratinocytes known as 11 Clear cells 11 because of their appearance
in routine paraffin-embedded material. They may be distinguished by the
absence of desmosomal attachments to adjacent cells (Breathnach, 1980).
These dendritic cell types include melanocytes, Merkel cells, and Langerhans cells, all of which may also be distinguished by the presence or
absence of ultrastructural organelles as well as by specific light microscopic techniques. All three cell types are dendritic, exhibiting
branched cytoplasmic processes of varying dimensions.
Melanocytes are derived from an embryonal neural crest cell population which synthesizes melanin and transfers it to other cells of the
epidermis or oral epithelium. The Merkel cell complex represents a slowly
adapting mechanoreceptor, the exact mechanism of which has yet to be established. (Iggo, 1969) Langerhans cells have been identified in the
oral mucosa of many species (Waterhouse and Squier, 1967; Barker, 1967;
Schroeder and Theilade, 1966; Hashimoto et al.; 1968; Sagebiel and Clarke,
1970; Hutchens et al.; 1971; Listgarten, 1972; Hill, 1977; Burkhardt,
1979; Newcomb, 1982). Squier (1969) demonstrated the presence of both
melanocytes and Langerhans cells in whole epithelial

she~ts

of oral mu-

cosa in the rat. Szabo (1967) reported similar numbers of melanocytes
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per square millimeter in human oral mucosa as in epidermis. He did not
quantitate the average number of melanocytes in the various oral regions.
Langerhans cells and melanocytes were quantitated in vestibular
gingiva, hard palate, tongue, cheek mucosa, and the skin of the external
lip of Rhesus monkeys ·(Hutchens et al., 1971).

DOPA and osmium iodide

reactions were used to identify basal and suprabasal dendritic cells by
light microscope.

Electron microscopy was used to confirm the presence

of basal melanocytes and suprabasal Langerhans cells.

Basal dendritic

cells were more numerous in pigmented than unpigmented areas, but suprabased cells did not vary with degree of pigmentation.

The number of

Langerhans cells in heavily keratinized areas such as gingiva, palate,
and the dorsal aspect of the tongue, was significantly greater than in
areas which appeared unkeratinized.

The largest number of suprabasal

cells was observed in the epithelium of the dorsum of the tongue.
Langerhans cells were identified within the crevicular epithelium.

Few
Hut-

chens et al., suggested a direct relationship between Langerhans cells
and the degree of keratinization.
Hill in 1977 studied neonatal rat palatal mucosa using the ATPase
staining reaction described by Wolf and Winklemann.

He found an increase

in epidermal Langerhans cells during the first 12 days after birth which
appeared to remain constant from 12-33 days.

Langerhans cells were iden-

tified as rounded masses of ATP positive cells with short dendritic processes during the first two days.

By four days there was a change in

number and distribution of langerhans cells observed to the typical dendritic pattern. This difference may be a response to antigenic stimulation

9
or merely a functional maturation process.
Bos and Burkardt (1979, 1980) examined interepithelial cell populations in germ free, specific pathogen-free, and conventionalized mice
(in which an oral flora was allowed to develop) by light and electron
microscopy.

They found in the epithelium of the tongue a mean of 7.4

cells per 1000 basal cells. After conventionalization a significant increase to 14.4 interepithelial cells per 1000 basal cells was observed.
A basal value for Langerhans cells was determined in germ free mice. Lymphocytes and Langerhans cells were classified and quantified solely on
the basis of morphologic characteristics.

The light microscopic tech-

niques used by this group have not been shown to be cell specific for
Langerhans cells.

Bos and Burkhardt (1980) felt that an increase in lym-

phocytes and Langerhans cells was in response to external antigenic challenge.
The degree of keratinization of the oral epithelium has been observed to decrease when gingival inflammation is present (Weinmann and
Meyer, 1959).

If there was a positive direct relationship between the

number of Langerhans cells and the degree of keratinization the Langerhans cells numbers would be expected to decrease as clinical inflammation
increases.

Newcomb et al ., (1982) examined attached gingiva as plaque

was allowed to accumulate.

This group used a modification of the ATPase

method as proposed by Juhlin and Shelley (1977).

Langerhans cells ap-

peared to become more dendritic in shape after 8 days of plaque accumulation than at day 0.

At 21 days the same number and morphologic appearance

was noted as at 8 days.

As dental plaque accumulated adjacent to and on
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attached gingiva there was a statistically significant increase in Langerhans cells in the stratum spinosum. This observation would seem to negate
the possibility of a relationship between Langerhans cells and keratinization.
Bos and Burkhardt (1981) studying the murine oral mucosa reported
a low mitotic rate for Langerhans cells as opposed to typical keratinocytes.

These results were in agreement with previous studies of epidermis

by Mackenzie (1970) and Patten (1974).

These studies indicated that the

Langerhans cells may migrate into stratified squamous epithelium of the
skin and oral mucosa as immature progenitor cells. It also seems reasonable that this might be a recirculating cell population in exchange with
cells of the T-cell areas of the local lymph nodes.

Necrosis of the cells

is not logical since cells are not seen in a stage of disintegration or
in the stratum corneum where remnance might be shed._
The recent research discussed has up to this point had a significant effect on our understanding of contact allergy of the skin.

Langer-

hans cells may as well play a major role in delayed hypersensitivity
reactions of the skin and oral mucosa and changes in Langerhans cell function could be the basis of certain oral pathologic manifestations.
C.

Ultrastructural Characteristics
~irbeck

et al.; {1961) established the basic criteria which permit

visualization with the aid of an electron microscope and distinguishes
them from melanocytes and Keratinocytes.
1)

A clear cytoplasm

2) A lobulated nucleus

11

3) The absence of desmosomes or tonofilaments
4)

The absence of premelanosomes or melanosomes

5)

The presence of a distinct organelle now referred to as "Langerhans
cell granule" or Birbeck granule 11
The cytoplasm of the Langerhans cell possesses all the characteris-

tics of a cell engaged in active metabolic activity and in protein synthesis.

Both smooth and rough endoplasms reticulum are present along

with centrioles.

Free ribosomes are of relatively inconsistent numbers

but they are very numerous in some cells.

The Langerhans cell has a well

developed Golgi apparatus and often times two or more Golgi regions can
be observed in one plane of section of a single cell.

Typically stacked

cisternae are found to make up this Golgi, which may be dilated and consist of multiple small vesicles at its concave face and lateral margins.
Also a variety of vesicles of different sizes are present in the cytoplasm and may show a fuzzy coat on the internal face of their membrane.
The vesicles with the fuzzy coat represent cross sections of the vesicular
portions of the Langerhans cell granules.

Oblong granules have also been

described to occur rarely with a dense matrix and a trilaminar limiting
membrane.

(VJong 1971, Ze 1i ckson 1966) •

Under electron microscopic observation the outlines of the cells
are irregular but do not appear to be dendritic since the sectioning is
rarely done through several dendrites.

However, images of dendritics

sectioned cross-sectionally or longitudinally are easily observed interspersed between the keratinocytes and throughout the epidermis.

(Wolf,

12
1972).

In these sections of the epidermis the cytoplasm of the Langerhans

cells appears relatively clear as compared to the surrounding keratinocytes.

The cytoplasmic membrane is devoid of desmosomes although it is

in close proximity of the membranes of adjacent keratinocytes and usually
allows no

dilation~

of the intercellular space.

The nucleus is lobated

or folded, however, round nuclei may be occasionally found.
The most surprising feature of the cytoplasm is the absence of tonofilaments.

There are filaments of a different nature present but they

are not always present in all parts of the cytoplasm consistently.

At

times they are regimented, ordered parallel strands and are similar to
those found in melanocytes or macrophages.

As with many of the other

features, it has not yet been elucidated whether their occurence is variable or the different tissue processing methods and stains may affect
their visualization.
The Langerhans Cell Granule
The chemistry of the Langerhans cell granules has yet to be clearly
defined.

No enzymatic activity has been observed in these granules up

to this point in time.

They are stained intensely with the reaction

product of the osmium-zinc-oxide procedure

(Niebauer, 1969).

Intracy-

toplasmic granules are osmium-zinc-iodide positive, however, the granules
which have come in contact with the cytomembranes are not
1969).

(Niebauer,

Niebauer assumed that it was a lipid substance responsible for

the chemical nature of the material responsible for the metallic deposits.
Birbeck (1961) described the granule as a rod-shaped organelle with
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a central linear, striated density.

One of the ends of the cell may ex-

hibit a partly expanded limiting membrane which has been described as resembling a tennis racket (Zelickson, 1965).

These forms have been pro-

posed as sectional areas of disc-shaped organelles and their vesicular
portion as a formative stage (Birbeck, 1961).
The most common electron microscopic picture is that of a rod-like
profile with rounded ends and a limiting membrane approximately 60 A thick.
The inner face of this membrane is lined by a leaflet composed of small
particles spaced at 50-60 A intervals {Wolff, 1967).

In between the lim-

iting membranes of the granule there is a linear density with a periodical
striation which has been described as 50-50 A (Wolff, 1967; Zelickson
1965) or as 90 A {Birbeck, 1961).

It represents a lamella made up of

electron opaque particles separated by 50-60 A wide spaces and aligned as
two parallel lines. (Wolff, 1967).

These are often continuous with vesicles

which are located either at one end of the granule, or its center with
rod-like profiles projecting from its circumference.

The vesicular frag-

ment has a clear center and the inner side of its membrane displays a
fuzzy coat which, in good sections seems to be organized into regularly
spaced granular particles which appear to be similar to the particles
lining the membrane of the rod-like portion {Wolff, 1967).
The Langerhans cell granules appear to be distributed randomly
within the cytoplasm but they are frequently seen in a close relationship
with the Golgi region.

The vesicles with a fuzzy internal coat are found

interspersed between Golgi vesicles or adjacent to the lateral portions
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of Golgi cisternal (Wolff, 1972).

The granules also have been reported

in the cell periphery, although less frequently.

They may be attached to

the plasma membrane with their interior opening into the intercellular
space (Wolff, 1967); (Ze l i ckson 1965); CBreathnach 1964); (Hashimoto 1968).
They are never, however, totally discharged into the extracellular compartment.
The granules appear as oval bodies exhibiting a two-dimensional
square lattice of particles if cut tangentially
1961) (Zelickson 1965).

(Birbeck &Breathnach

These appear to merge into a cross-striated pat-

tern in different planes of the same section.

Three dimensional models

of the Langerhans cell granules have been proposed by Wolff (1967) and
Sagebiel (1968) and were later confirmed by Breathnach (1973) utilizing
a freeze fracture technique and more recently by Caputo (1976) with a
similar technique. As a result of cytolysis Langerhans cell granules
have rarely been identified in the intercellular spaces of the epidermis
(Wolff, 1969).

Granules are not found in keratinocytes except in a situ-

ation where the entire Langerhans cell is phagocytosed by the epidermal
cell.
Lysosomes
Langerhans cells have been reported to contain a variety of lysosomes
which have been described as single membrane limited dense bodies (Breathnach, 1964) containing acid phosphatase (Wolff, 1970).

They are lined by

a single triple-layered membrane and contain a granular matrix, lamellae,
whorled membranes (Breathnach, 1964) (Zelickson, 1965) or myelin-like
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structures (Bell, 1961).

Acid phosphatase is packaged in the Golgi system

then is transferred to either autophagosomes or heterophagosomes which are
thus transformed into secondary lysosomes.

This is consistent with what

is known concerning the lysosomal system in general. ((DeDuve, 1966).

Mul-

tivesicular bodies, sacks or vacuoles which have been described intracytoplasmically probably belong to the lysosomal system.

Often times debris

or remnants of organelles i.e. Langerhans cell granules may be found
(Breathnach, 1964) which would categorize these vacuoles as autolysosomes.
D.

Demonstration and Identification of Langerhans Cells

1.

Hematoxylin and Eosin
This type of staining is of little or no value for certain identi-

fication of Langerhans cells.

The cells appear in the suprabasal layers

as high-level "clear cells" exhibiting deeply staining nuclei which is
surrounded by apparently "clear"

cytoplasm~

Keratinocytes are similarly

stained therefore cannot be distinguished from Langerhans cells (Clark,
1961).
2.

Gold Impregnation
This is the classical technique most commonly employed for examina-

tion of the gross morphology and the distribution of cells.

There are a

variety of methods available, (Carey (1942); Ferreira-Narques (1951) and
Paul Langerhans himself impregnated epidermal specimens with gold chloride.
The characteristic dendritic shape is well visualized in a
impregnated specimen.

w~ll

Little detail of the internal structures of the

cell, however, with the exception of a nucleus can be discerned.

As
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previously mentioned there are several variations in the gold chloride impregnation.

These techniques, however, all have the disadvantage requir-

ing diligent preparation and inconsistent results have been reported
(Becker, 1952).

In adequately impregnated specimens this stain appears

to be specific for Langerhans cells as verified by electron microscopy
(Breathnach 1965; Zelickson 1968).
3.

Osmium Iodide
The Champy-Coujard technique was utilized by Niebauer (1956), Mish-

ima and Miller Milinska (1961) and was actually considered to be more consistantly reliable than gold impregnation (Miller Milinska, 1961).

The

procedure, however, is not specific for Langerhans cells since melanocytes
or keratinocytes are also stained.

Hutchins (1971) also used this method

in examining the oral mucosa of Rhesus monkeys.

The osmium iodide reac-

tion stained the entire dendritic cell black, obliterating cytoplasmic
detail.
4.

ATPase
For the demonstration of Langerhans cells within human, mouse,

guinea pig and rhesus monkey epidermis the demonstration of a formalin
resistant and sulphydryl dependent adenosine triphosphatase (ATPase) is
a reliable and Langerhans cell-specific procedure (Jarret and Riley, 1963,
Mustakallio (1963) Bradshaw (1963) Wolff (1962) Mackenzie and Squier
(1975).

Langerhans cells were also identified by this method in rat pa-

latal mucosa and human gingival epithelium (Hill, 1977); (Barker, 1967);

,

(Waterhouse and Squier, 1967); (Newcomb, 1982). With proper techniques
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the morphologic results are good, reliable, and the stain is specific for
Langerhans cells.
vantage.

This enzymatic technique does, however, have a disad-

It is not known whether all Langerhans cells react positively

at all times and since the method depends upon enzyme activity, it may be
influenced or inhibited in pathologic conditions.

There has of yet been

no explanation of the function of ATPase on the cell surface.

An associa-

tion was made between plaque accumulation and an increase in Langerhans
cells in human attached gingiva using the ATPase methods (Newcomb, 1982).
A modification of the adenosine triphosphatase method has recently been
described which involves prolonged fixation in cacodylate formalin and
reportedly permits a more reliable visualization of cells (Robins and
Brandon 1981).
5.

L-Dopa and Amines
Human epidermal Langerhans cells have been reported to be capable

of taking up L-dihydroxyphenylalanine (L-dopa) and the catecholamines
dipamine and noradrenaline when exposed to these in vivo (Falck, 1976;
Axelsson, 1978). A chemical reaction with formaldehyde transforms L-dopa
and the catecholamines into strongly fluorescent molecules within the
tissue.

The dopa fluorophore of the Langerhans cell has an excitation/

emission which is easily distinguished from the formaldehyde-induced
fluorophore of cysteinyldopa, a normal constituent of human melanocytes.
This seems to be a reliable method for the visualization of Langerhans
cells within normal epidermis.

When skin biopsy specimens from antigen-

ically challenged sites of hapten-sensitized animals are treated though,
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fluorescent clusters of both dendritic and nondendritic cells are observed.
This suggests that different mononuclear cells uptake L-dopa and catecholamines (Sjoborg, 1978).
6.

a.-D

r~annose

Using the a.-D mannose technique to stain Langerhans cells the cell
body but not the dendrites are visualized (Elleder, 1975).
7.

HLA-DR and Ia antigens
A region of chromosome-17 of the mouse called the Ia region or im-

mune response region contains a series of genes which appear to be integral to a number of cell surface interactions related to the immune response . (McDevitt et al., 1976; David, 1976).

Many of these Ir genes are

capable of producing proteins on a cell surface that will be perceived as
antigens if introduced into the body of an individual of different genetic
background (Albert, 1977).

A number of articles have recently dealt with

the possible significance of the Ia antigens presence on Langerhans cells
(Streilein & Bergstresser, 1980; Stingl et al., 1980a; Stringl et al.,
1980a; Stringl et al., 1980b; Rowden, 1980; Rowden, 1981).
HLA antigens are glycoproteins on the surface of most eucaryotic
cells.

The glycoproteins are unique to the cell surface of an individual

and enable the immune system to 11 fingerprint" a given cell as its own.
The HLA antigens are coded for by several genes on the short arm of chromosome-6 in humans is referred to as the major histocompatibility complex
(MHC) or HLA (Albert, 1977).

Humans do not produce antibodies against

their own HLA antigens, however, they will evoke an immune response if
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transplanted into a person of dissimilar genetic makeup.

The genetic

loci which produce HLA antigens are termed A, B, C, D and DR and their
products HLA-A, HLA-8, HLA-C, HLA-D, and HLA-Dr.

The major histocompati-

bility complex controls the reaction of animals to various immunologic
challenges. (Sasazuki et al., 1977) Most of this immunologic activity
may be restricted to the area of the D locus.
HLA-DR antigens of humans and murine Ia antigens are thought to be
analagous •. (Balner, 1979)

The murine MHC has been much more extensively

investigated because of the availability of inbred populations for study.
Rowden et al, (1977) and Klareskog (1976) reported that Langerhans
cells express cell surface !a-like antigens.

At the present time it seems

that only Langerhans cells or their precursors express Ia antigens on their
cell surface.

Frozen sections may be stained utilizing the appropriate

anti-Ia antisera comercially available and a peroxidase-labeled secondary
anti-immunoglobulin~

(Rowden, 1980)

8. T-6 Antigen
It has recently been reported that monoclonal antibody anti T-6 reacts
with most immature human thymocytes, but not with circulating peripheral
T cells.

(Reinherz et al., 1980; Bahn et al., 1980) This antigen is

present when the cells are in the thymic cortex but may be lost and apparently replaced by other antigens when the cells mature into circulating
peripheral T cells. T-6 has been identified as a glycoprotein with a
molecular weight of 49,000 daltons.

(Terhorst et al., 1981; Van Agthoven

and Terhorst, 1982; Cotner et al., 1981) The T-6 antigen has recently
been detected on the surface of Langerhans cells (Murphy et al., 1981;
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fithian et al ., 1981)

Immune-electron microscopy has been utilized to

confirm the specificity of T-6 for Langerhans cells in the epidermis.
{Murphy, 1981; Murphy, 1982; Dubertret, et al.; Chu, 1982)
Staining is of a similar protocol as that used for HLA-DR antigens.
Basically, frozen sections are stained with nonoclonal mouse anti T-6
reagents, followed by goat antimouse IgG usually with a peroxidase label.
There are now many commercailly available anti-T-6 reagents.
9. S-100
Moore {1965) originally extracted the S-100 protein from bovine brain at
which time it was thought to be unique to the nervous system.

It is an

acidic calcium-binding protein (Klee et al., 1980) composed of three subunits, (Dannies and Levine 1971) and has a molecular weight of 21,00024,000 daltons.

(Moore, 1965; Dannies and Levine 1971). There are several

reviews concerning the biochemical aspects of S-100 protein (Moore, 1972;
Bock, 1978; Isobe and Okuyame, 1978; Varon and Somjen, 1979), although
the biologic function of the protein remains unknown.
S-1 00 protein has been demonstrated primarily in the neurons of the·
CNS (Hyden et al., 1966; Sriridov et al., 1972; Hansson H-A et al ., 1976),
however, outside the CNS S-100 has only been identified in Schwann cells
and satellite cells of the dorsal root and autonomic ganglia.(Stefansson,
1982)
S-100 protein has recently been reported to be present in Langerhans
cells of normal human epidermis (Cocchia et al., 1981). The protein has
also been identified with interdigitating reticulum cells (IDC) in the
paracorti ca 1 zones of lymph· .nodes. (Takahashi et a1., 1981), which a1ong
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with veiled ce 11 s of lymph, may be re 1a ted to Langerhans ce 11 s ( Drexhage
et al., 1979; Thorbecke et al., 1980; Veldman & Kaiserling, 1980;
Hoefsmit et al .,

1~80;

Hoefsmit et al.; 1982).

Staining of epidermal Langerhans cells can be accomplished using
'

either a peroxidase antiperoxidase (PAP) method (Sternberger et al., 1970;
Sternberger, 1979) or an avidin-biotin method (Hsu et al., l98la; Hsu et
al., l98lb).

CHAPTER III
MATERIALS AND METHODS
A.

SELECTION OF PATIENTS
Thirteen adult human subjects, four females and nine males, ranging

in age from 29 to 52 were selected for this research.

They were diagnosed

as having Type III moderate periodontitis or Type IV severe periodontitis
according to the American Academy of periodontology's (1977) definition of
case types.

None of the patients had received a prophylaxis within the

last six months.
To participate in the study, the patients were required to have at
least one area of attached, marginal, and/or papillary gingiva which displayed moderate to severe inflammation as assessed by the criteria of the
Gingival Index of Loe and Silness (1963) as modified by Loe (1966). Periodontal surgery was included as a possibility in the future treatment plan
of each patient.

None of the patients had a history of rheumatic fever,

hepatitis, or other systemic complicating factors.
oral pathology was also established.

An abscence of other

The females included in the study

were neither pregnant, lactating, nor taking oral contraceptives.
Each patient received an oral explanation of the study.

It was

explained that a portion of tissue normally discarded during routine periodontal surgery would be retained for microscopic examination as part of
a research project.

This study was reviewed by the chairman of the Loyola
22
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University Medical Center Institutional Review Board for the Protection
of Human Subjects (IRB) before commencement.

In reply to submission of

a thesis outline it was decided that there was no need for IRB submission
as long as the specimens were obtained during a surgical procedure which
the patient undergoes for reasons unrelated to the study.

Other stipula-

tions were that the specimens were not identified in terms of a patient's
name, and the cost of the study was not billed to the patient.

Patients

were required only to sign the routine consent and permit for periodontal
surgery used by the Loyola University School of Dentistry.
Although thirteen subjects agreed to participate in the research,
eleven completed therapy which included periodontal surgery.

One of the

female subjects had to be eliminated from the study because of an excellent response to initial therapy.

This included scaling and curettage,

after which periodontal surgery was not indicated as assessed at the time
of reevaluation.

After a reevaluation the patient was placed on three

month recalls for prophylaxis as indicated, and no further periodontal
treatment was performed.

One of the male subjects withdrew from the

dental clinic and, subsequently, the research participation.
B.

EXPERIMENTAL DESIGN
An area in the oral cavity of each subject which showed clinical

inflammation and was scored as GI=2 or GI=3 was left untreated until
periodontal surgery was performed.

This usually consisted of an area of

two to three teeth and the adjacent attached, marginal, or papillary
gingiva associated with them.

In a majority of cases these teeth were
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separated by an edentulous area from the teeth which would be treated.
The remaining teeth were scaled and root planed.

Oral hygiene instruc-

tions were initially given and were reinforced at each appointment. These
appointments were from thirty to forty-five minutes in length and ranged
from six to twelve weeks.

Upon completion of this initial phase of

therapy each subject•s response to initial treatment was evaluated and a
rationale for periodontal surgery was established.

The female subject

previously discussed was withdrawn from the study at this time.

The area

which at the initial examination displayed clinical inflammation {GI=2)
received a lower score (GI=O) at the surgical evaluation.
ment was apparently the result of improved home care.

This improve-

The oral tissues

were scored at the time of the surgical evaluation and again at the surgical appointment as assessed by the Gingival Index as modified by Loe
(1966).
PERIODONTAL SURGERY
Blood pressure, respirations, and pulse were assessed at the beginning of each surgical appointment. Anesthesia was administered using 2%
lidocaine with 1/100,000 epinephrine.

This was administered by nerve

block whenever possible, and care was taken not to directly infiltrate
anesthetic solution into the tissue scheduled for microscopic examination.
The initial incision during periodontal surgery was made with a
#15 scalpel blade approximately two millimeters from the coronal edge of
the face marginal gingiva.

The tissue coronal to this incision was care-

fully freed from the tooth surfaces and immediately placed in prepared
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vials of (RPMI).

Each tissue specimen had been scored by the Gingival
.

Index modified by Loe (1966) immediately prior to periodontal surgery
and placed into vials marked as
normal 11 •
zero.

11

clinically inflamed 11 or 11 clinically

Clinically normal tissue received a Gingival Index score of

Full mucoperiosteal flaps were then reflected and routine perio-

dontal surgery was performed including osseous recontouring as indicated.
The collar of tissue retained for microscopic examination is normally
discarded after reflection of mucoperiosteal flaps during surgery.

The

surgical areas were sutured and protected with Coe Pak for one to two
weeks post-operatively.

There were no complications regarding surgical

procedures or post-operation healing associated with any patients.
The qualitative state of the gingival soft tissues were assessed
by the Gingival Index {GI) of Loe and Silness (1963) as modified by Loe
(1966).

In the Gingival Index system of scoring oral tissues, each of

the four gingival areas of the tooth is given a score from zero to three.
The scores from the four areas of the tooth are added and divided by four
to give the GI for the tooth.
C.

STAINING
Specimens from each patient will be placed into individual vials

marked as "clinically normaP or 11 clinically inflamed 11 •

These were

stored in RPMI for up to three hours under refrigeration at Loyola University Dental School.

The specimens were then transported to the Path-

ology Laboratory of the Loyola University Medical Center.

Each section

was immediately divided into three sections of approximately equal length
under a dissecting microscope.

Each section was then prepared
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specifically for the staining protocol to be utilized at a future date.
The three different procedures were as follows:
1.

Fixed in buffered formalin for eight hours at room temperature
Rinsed with Buffer
Paraffin embedded for Mayers Hematoxylin and Eosin and S-100 staining

2.

Fixed in formaldyhyde-cacodylate solution for one hour at 0-4°C
Washed in phosphate buffered saline (PBS)

3.

Frozen and stored at -80°C for future ATPase staining
The initial ATPase staining procedure utilized was essentially a

modification of earlier adenosine triphosphatase methods (Wachstein and
Meisel, 1957; Juhlin and Shelley, 1977; and Mackenzie and Squier, 1975)
which employed prolonged fixation in cacodylate formalin as described by
Robins and Brandon (1981).

The last four specimens were stained utiliz-

ing a procedure described by Wachstein et al. (1960).

The staining pro-

tocol used for S-100 was a technique which entailed incubating with S-100
antibody, antigen, and antibody (thus the name self sandwich) as described
by Hsu and Ree (1980).
In staining for OKT6 and HLA-DR the technique utilized was essentially the same as that described by Rowden (1981).

Frozen sections for

HLA-DR were stained with the appropriate anti-IA antisera commercially
available and a peroxidase labeled secondary immunoglobulin (Rowden (1981).
For OKT6 the frozen sections were stained with monoclonal mouse anti T-6
reagents, followed by goat antimouse IgG with a peroxidase label.
D. MICROSCOPIC EXAMINATION
A total of twenty-four tissue specimens were obtained from eleven
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patients during periodontal surgery.

After sectioning under a dissecting

microscope and preparation as described in the previous section the slides
were grouped for microscopic examination.

Most slides included three

serial sections from the same section and were approximately 5 microns in
thickness.

A total of fourteen slides were prepared for each of the

eleven patients with a total of 154 slides being examined.

The following

slides were prepared and examined.
Hematoxylin and Eosin - clinically normal
Hematoxylin and Eosin - clinically inflamed
ATPase - clinically normal
ATPase - clinically inflamed
ATPase - control
OKT-6 - clinically normal
OKT-6 - clinically inflamed
OKT-6 - control
HLA-DR - clinically normal
HLA-DR - clinically inflamed
HLA-DR - control
S-100 - clinically normal
S-100 - clinically inflamed
S-100 - control
The slides were examined for each of the eleven subjects with the aid of
a Spencer light_microscope.

All slides were qualitatively examined for

the presence of Langerhans cells.
noted:

The following parameters were also
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Morphology of Langerhans Cells
Patterns of arrangement of cells
Presence or absence in lamina propria
Position in epithelium
Orientation
Staining reactions with other cells
Approximate numbers of cells
A quantative procedure was also undertaken using the sections prepared
with the OKT-6 staining protocol.

Langerhans cells were quantitated

using aQ13 mm square standardized grid at a 400X magnification.
dom number of fields for each section were examined.

A ran-

OKT-6-positive

staining cells (nuclei) were counted and a mean was established for each
specimen.
E.

STATISTICAL ANALYSIS
Eleven gingival specimens were obtained and stained with the OKT-6

method described by Murphy (1981).

Of the eleven specimens stained for

Langerhans cells, seven of these were qualitatively judged acceptable
for quantitation.

The four slides that were omitted from the quantita-

tion of Langerhans cells were done so because of inconsistent sectioning.
Staining by this method was consistent for all sections.

All Langerhans

cells were also identified in tangential sections (Fig 19), although
quantitation was not performed because depth of the section was impossible to determine.

Langerhans cells have been described traditionally in

the suprabasal layers of the epithelium.

Langerhans cell numbers were

compared in the clinically normal gingival specimens vs. clinica_lly
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inflamed specimens.

Statistic~l

analysis was performed utilizing a

students two sample T test (Fig. 27).

CHAPTER IV
RESULTS
There were no complications to the surgical procedures performed on
the eleven patients involved with this research.

Healing was uneventful

in all cases.
A.

Hematoxylin and Eosin
Inflammation was identified histologically in the hematoxylin and

eosin stained sections. The clinically inflamed slide preparations were
all easily distinguished from the clinically normal specimens.

There

were, however, different degrees of inflammation present in all the specimens.

The sections of clinically normal human gingiva were identified

by the presence of intact epithelium and connective tissue in the absence
of pathologic changes of inflammatory cell infiltrates {Fig 1 and 2). The
sections observed in the clinically inflamed group were characterized by
edema, and engorged capillaries in the connective tissue {Fig 3 and 4).
An infiltrate consisting of large numbers of lymphocytes, plasma cells,
and polymorphonuclear leukocytes was consistently observed in the clinically inflamed group {Fig 3 and 4).
B. ATPase
A technique described by Robins and Brandon {1981) which involved
prolonged fixation in cacodylate formalin was initially utilized (Fig 22).
The first seven specimens were prepared in this manner in hopes of the
30
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technique being an improved method as described by Robins and Brandon
{1981).

Due to technical problems of an unknown etiology, Langerhans cells

were not identified in these sections (Fig 5 and 6). A classical ATPase
staini·ng method described by Wachstein and Meisel (1960) was utilized for
the final four specimens in anticipation of improved visualization of
Langerhans cells (Fig 21).

Langerhans cells were identified in sections

stained by this technique in the stratum spinosum above the basal lamina
(Fig 7 and 8).

Although Langerhans cell nuclei were identified in these

sections the cells were not well visualized in terms of orientation or
morphology.

Qualitatively, there seemed to be an increased number of

Langerhans cells in the clinically inflamed group (Fig 8) in comparison
to the clinically normal (Fig 7) Langerhans cells could only be identified in the epithelium in these sections.

Blood vessels in the lamina

propria were deeply stained obscuring any Langerhans cells which might
have been identified (Fig 7 and 8).
C. S-100 Protein
A technique for staining Langerhans cells based on the presence of
a cytoplasmic marker, S-100 protein was utilized as described by Hsu 1980
(Fig 23).

Qualitatively this proved to be a reliable cell marker and

Langerhans cells were easily visualized.

Dendrites of the cells were

not well depicted although cell nuclei stained deeply (Fig 10 and 11).
Qualitatively, Langerhans cell numbers seemed to be increased in the
clinically inflamed specimens (Fig 10) in comparison to the clinically
normal (Fig 9).
although rarely.

Langerhans cells were observed in the lamina propria,
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D.

Ia (HLA-DR)
The staining technique for Ia (HLA-DR) utilized was described by

Murphy (1981}

(Fig 24).

Langerhans cells were well stained and very

easily distinguished from epidermal keratinocytes (Fig 13).

Langerhans

cells were most often identified in the stratum spinosum, but were occasionally seen in the lamina propria.

Dendrites were prominently stained

by this method (Fig 14 and 15). The cells themselves were more easily
identified in clinically inflamed specimens (F,ig 13).

When qualitatively

comparing clinically normal (Fig 12) to clinically inflamed (Fig 13)
gingival biopsy sections, there seemed to be an increased number of cells
in the clinically inflamed sections. The cells also seemed more dendritic
and better developed morphologically (Fig 13 and 15).
E.

OKT-6
Langerhans cells

w~re

well visualized in specimens prepared by a

technique for OKT-6 described by Murphy (1981).

The cells themselves

were well differentiated with prominent dendrites and nuclei (Fig 17, 19
and 20).

Langerhans cells were most often identified within the stratum

spinosum, although they were sometimes seen in the lamina propria.

Den-

drites of the cells were observed stretching upwards towards the surface
of the epithelium in clinically inflamed specimens (Fig 17, 20}.

Langer-

hans cells seemed to form a net or continuum just below the stratum corneum.

Three such cells are seen in Fig 18. The dendrites of these cells

appear to overlap although it is difficult to interpret in a two dimensional representation.

Langerhans cell numbers were qualitatively and

quantitatively shown to be increased in clinically inflamed (Fig. 17 and
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27) when compared to clinically normal (Fig 16) specimens.

This was con-

firmed statistically (P = .01), and an approximate five fold increase was
noted.

This result is even more significant when one considers that only

nuclei of epithelial Langerhans cells were counted.

Although dendrites of

Langerhans cells were observed they were not considered in the data.

A

Langerhans cell stained with OKT-6 with a prominent nucleus and dendrites
is noted in Fig 19, which is a tangential section.
For specimen #1 clinically normal human gingiva, the mean number of
Langerhans cells identified in a 0.13 mm 2 microscopic field at 400X was
0.19048 with a standard deviation of 0.397.

The mean number of Langerhans

cells observed in specimen #1 clinically inflamed in a 0.13 mm 2 microscopic field was 1.200 and the standard deviation was 1.00.

The increased

numbers of Langerhans cells in the clinically inflamed group was shown by
a student•s two sample T test to be a significant increase at 0.01.

For

specimen #2 clinically normal the mean number of Langerhans cells identified in each field was 0.33333 and the standard deviation was 0.488.

The

mean for the clinically inflamed of specimen #2 was 1.3864 and the standard deviation was 1.06.
at the 0.01 level.

This increase was shown by a T-test significant

The mean number of Langerhans cells identified in a

0.13 mm 2 microscopic field at 400X for specimen #3 clinically normal was
0.500 with a standard deviation of 0.798.

The mean for specimen #3

clinically inflamed was 0.84615 with a standard deviation of 0.881.
was not shown to be a significant increase at the 0.05 level.

This

The mean

for specimen #4 clinically normal was 0.26786 with a standard deviation
of 0.522.

The mean for specimen #4 clinically inflamed was 0.89286 with
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a standard deviation of 0.824.

This increase was shown by a T-test to

be statistically significant at the 0.01 level.

The mean number of

Langerhans cells identified in a 0.13 mm 2 microscopic section for specimen #5 clinically normal was 0.171429 with a standard deviation of 0.26.
The mean number identified in specimen #5 clinically inflamed was 0.64286
with a standard deviation of 0.745.

This increase in the clinically in-

flamed specimen was shown to be statistically significant at the 0.01
level.

The mean number of cells identified in specimen #6 clinically

normal was 0.12500 and the standard deviation was 0.334.

For specimen

#6 clinically inflamed the mean was 0.71429 and the standard deviation
was 0.810.

This was shown to be a statistically significant increase at

the 0.01 level.

The mean number of Langerhans cells identified in a

0.13 mm 2 microscopic section of specimen #7 clinically normal at 400X
was 0.42857 with a standard deviation of 0.690.

The mean number identi-

fied in specimen #7 clinically inflamed was 1.4390 with a standard deviation of 0.976.

This was shown to be a statistically significant in-

crease for the clinically inflamed specimen at the 0.01 level.
F. Statistical Analysis
An increase in Langerhans cell numbers was observed for all clinically inflamed gingival tissue specimens when compared with clinically
normal gingival biopsies.
significant increase (P

This was shown by a student's T test to be a

= .01) in six of the seven specimens stained

with OKT-6 (Murphy, 1981) (fig 27). Langerhans cell numbers in approximately one square millimeter of·cross sectional epithelium were established (Table 15).

Increases in Langerhans cell numbers seen in the
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clinically inflamed gingival tissue specimens when compared to clinically
inflamed specimens ranged from two to ten fold (Table 15).

CHAPTER V
DISCUSSION
Clinical Assessment of Gingiva
In the present study gingival tissues were assessed for degree of
inflammation by the criteria of the Gingival Index System (Loe and Silness, 1963, Loe 1966).

Inflammation was later established histologically

in routine hematoxylin and eosin staining of specimens.

Oral epithelium

pale pink in color, stippled in texture, firm in consistency, and in the
absence of bleeding upon probing was considered clinically normal. These
gingival tissues received a Gingival Index score of zero.

Specimens dis-

playing moderate inflammation, redness, edema and glazing, in the presence
of bleeding upon probing received a Gingival Index score of two.

All

specimens in the present study which were considered to be clinically inflamed had received a score of two as assessed by the criteria of the
Gingival Index System.

(Loe and Silness, 1963, Loe 1966).

Gingival tis-

sues which displayed severe inflammation, ulceration, and tendency to
spontaneous bleeding were not included as specimens for the present study
because of problems with preparation, and difficulty of interpretation of
results.
Three patients were dropped from the study prior to periodontal
surgical procedures.

Significant improvements were noted as color changes

and probing indices.

This was apparently the result of the initial phases
36
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of therapy including scaling, root planing, curettage, and oral hygiene
instruction.

Clinical improvement was, however, also observed in areas

which had received no therapy.

It was assumed that this was a result of

the oral hygiene instructions and the meticulous home care by the patients.
These areas had received lower Gingival Index scores after the first phase
of therapy and were then excluded from the study.
Inflammatory infiltrates consisting of a few isolated polymorphonuclear leukocytes were sometimes observed in clinically normal specimens.
It should be kept in mind that although gingival tissues were scored as
clinically normal due to the appearance of the oral epithelial surface,
these tissues may have been associated with a submarginal inflammation.
The absence of overt inflammation was confirmed for each specimen histologically by examining the oral epithelial surfaces of the gingival specimens.

It was not established what degree of inflammation was associated

with the depths of the periodontal pockets involved.

Bleeding upon prob-

ing was not elicited in the clinically normal gingival tissue specimens.
Crevicular fluid indices were not utilized in the present study.
Comparison of Staining Techniques
Specific cell surface as well as cytoplasmic markers are useful in
identification of Langerhans cells.

The cytochemical composition of

Langerhans cells results in a variability of their reaction to the reagents used in staining.

OKT-6 is apparently a more reliable method of

staining Langerhans cells than ATPase, since it relies on a specific
antibody-antigen reaction.

In addition, the use of monospecific or mono-

clonal antibodies further adds to specificity.

It is not known whether
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all Langerhans cells react positively at a given time when utilizing
ATPase staining.

The ATPase technique relies upon an enzymatic reaction

which may be influenced by the active state of a particular cell or the
cell of the associated pathologic conditions.

Qualitatively OKT-6 was

more efficient for staining and identification of Langerhans cells than
ATPase in the present study, suggesting that cell surface antigenic determinants identified by the antisera may be subject to variation.
The use of S-100 protein as a cytoplasmic marker for the identification of Langerhans cells is a newer technique and is as of yet unperfected.
tives.

It has yet to be established which reagents are the best fixaTherefore, the type of fixative, concentrations of fixatives,

duration, and temperature of optimal fixation remains to be determined.
Since OKT-6 and HLA-DR staining were achieved on essentially unperturbed
specimens (frozen sections) such preparation artifacts were evaded.
S-100 protein technique is not however, without its advantages.

The

It can

be performed retrospectively on tissues obtained from the files of the
pathology laboratory.

As utilized in the present study S-100 protein

seemed to be a reliable method for the identification of Langerhans
cells in oral epitehlium.

The cytoplasm and nuclei was stained to a

much better degree than the dendrites of Langerhans cells.

Clearly

further studies are required on the parameters mentioned above before
S-100 staining may be fully assessed with respect to efficiency versus
staining for surface antigens such as OKT-6 and HLA-DR.
The present study suggests that OKT-6 and Ia (HLA-DR) were
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qualitatively the best stains for the identification of Langerhans cells
of the reagents tested.

These two techniques were very comparable in

Langerhans cell identification properties but OKT-6 was qualitatively
judged to be the best technique utilized.

In light of other recent

studies concerning Ia (HLA-DR), OKT-6 seems to be a more reliable marker
for Langerhans cells.

Larger numbers of OKT-6-positive cells have been

identified in epidemics compared to HLA-DR.

HLA-DR may not be cell

specific for Langerhans cells but may be synthesized by other cells.
(Daynes et al., 1983).

Furthermore HLA-DR has also been reported to be

present on the cell surfaces ofT lymphocytes (Evans et al., 1978) and
on damaged keratinocytes (Lampert et al., 1981).
The only situations in which keratinocytes have been shown to express cell surface Ia (HLA-DR) antigens are those in which some pathological process has induced some degree of peturbation or damage.

In graft-

versus-host disease (Lampert et al., 1981), mycosis fungoides and lichen
planus, (Tjernlund 1979, 1980), disturbances in the activities of the
Langerhans cell population may be associated with an onset of Ia antigen
synthesis by keratinocytes.

Such Ia bearing keratinocytes have, however,

not been shown to be immunologically active as judged by their capacity
to present antigens or stimulate in a mixed lymphocyte reaction (MLR)
(Breathnach, 1983).

Whether keratinocyte presentation of Ia antigen in

such situations is of immunological significance or is an epiphenomenon
remains to be seen.
An interpretation of staining reaction variability was performed

~-
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by (Harrist et al., 1983), using monoclonal antibodies in an immunoperoxidase procedure this group compared the numbers of T6-positive Langerhans
cells with HLA-DR-positive cells in normal skin.

These investigators

concluded that intraepidermal Langerhans cells and indeterminate cells
may be !a-positive or !a-negative. Thus, there may be a Langerhans cell
subset which is !a-negative and T6-positive.

This hypothetical subset

would not be identified as a result of Ia (HLA-DR) staining but would
react to OKT-6 preparation.

Langerhans cell numbers were shown to be

significantly underestimated when quantitated with Ia (HLA-DR).

Harrist

states that 11 Perhaps the Ia-positive/T6-positive subset represents an
activated state of Langerhans cells or a functionally distinct subtype 11
(Harrist et al., 1983).

It is interesting to note that in the present

study, sections stained with Ia (HLA-DR) and OKT-6 methods, the Langerhans
cells seemed to be more dendritic in the clinically inflamed sections.
The clinically inflamed specimens were most probably associated with a
response to antigenic challenge.

This finding is in agreement with the

conclusions of Hill (1977} who examined neo-natal rat palatal mucosa and
identified Langerhans cells as becoming more dendritic upon antigenic
challenge.
Langerhans Cells and Keratinization
The dendritic morphology of Langerhans cells seems to characterize
them as optimal immune surveilance cells due to the increased surface
area.

As an alternative, however, it has been suggested that this large

surface area may allow distribution of controlling substances involved

~·:
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in keratinization (Shah et al., 1981). A role has been considered for
Langerhans cells in the production of chalines influencing epidermal
turnover rates (Bullough and Lawrence 1968, Sagebiel et al., 1971, Patten
and Allen 1976).
The T6 glycoprotein seems to be somehow related to the keratinizing
environment.

As Langerhans cells migrate from the bone marrow through

the peripheral blood they are T6 negative.

It is not until the cells

arrive at the dermis where they are T6 negative or positive and eventually the keratinizing environment of the epidermis/oral epithelium when
they are T6 positive.

The identification of Langerhans cells with fewer

numbers of Birbeck granules by electron microscopy may be interpreted as
new arrivals in the process of developing into active cells.

It should

be mentioned at this point that Langerhans cells have been reported to be
absent in certain situations of keratinization (Wolff 1972, Lessard et al.
1968).

These isolated findings however, relate to the abnormal states

of the epidermis responding to tape stripping; therefore such findings
are questionable.

In all statements concerning the identification of

cells of Langerhans cell morphology but lacking Birbeck granules, the
problem of serial thin sectioning must be borne in mind.

This arduous

task has seldom been achieved so it is not certain if cells identified
as so-called indeterminate cells (i.e. lacking Birbeck granules) really
exist in significant numberso
The degree of keratinization of oral epithelium diminishes in the
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presence of gingival inflammation (Weinman and Meyer, 1959).

Newcomb et

al., (1982) demonstrated in oral epithelium an increase in Langerhans
cell numbers as plaque accumulated.

The present study demonstrated an

increase in Langerhans cells in inflamed gingival tissues apparently subjected to antigenic challenge when compared to tissues in the absence of
clinically and histologically determined inflammation.

There is always,

however, a certain degree of inflammation associated with this tissue.
If in fact, the degree of keratinization decreases in oral epithelium
with inflammation, one might expect Langerhans cell numbers to decrease.
This further confuses the role of Langerhans cells and the keratinization
process the facts concerning the question of Langerhans cells and keratinization remain unanswered at this time.
Langerhans Cells vs. The Monocyte-Macrophage
There have recently been the description of a number of similarities
reported between Langerhans cells and cells of the macrophage-monocyte
series.

Among these similarities are the facts that Langerhans cells

have adenosine triphosphatase (ATPase) activity (Wolff, 1967) and have
the ability to migrate (Silberg, 1973).

Rowden et al., {1977, 1978) and

Klareskog et al., (1977) have conclusively demonstrated that Langerhans
cells were the only cell in the normal human epidermis to express !a-like
antigens which have been shown to possess HLA-DR.

!a-like antigens have

been demonstrated to be integral for macrophage-antigen presenting functions (Rosenthal, 1978).

Stingl (1977) furthermore, concluded from his

studies that Langerhans cells are also the only epidermal cells which
express receptors for C3 and the Fe portion of IgG.

The same surface
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markers are present on cells of the macrophage-monocyte series.

Non-

specific esterase activity has also been linked to the Langerhans cell
(Berman, 1979}.

As previously discussed, Langerhans cells have the

ability in vivo to actively present antigens in lymphocyte stimulation
{Stingl, 1978}.

(Katz, et al., 1980,) indicated that epidermal Langerhans

cells were derived from a pool of precursor cells in the bone marrow. When
considering the similarities between Langerhans cells and cells of the
macrophage-monocyte series the finding of a mesenchymal origin for Langerhans is of paramount importance.
Recently, through immunohistochemical analysis utilizing S-100 protein Langerhans cells, indeterminate {Nakajima, 1982) cells of the epidermis (lacking Birbeck granules) and interdigitating cells (IDCS) in the
paracortical area of lymph nodes were studied in dermatopathic lymphadenitis situations.

All three of these cells were included in a S-100

positive, lysosyme-negative group.

Histocytes in lymphatic sinuses were

usually lysosyme-positive macrophages and were S-100 negative (Nakajima,
1982).

This presents a question concerning the possibility of a separate

lineage independent of the macrophage-monocyte system.

Further confirma-

tion of the heterogenicity of the macrophage series has been derived not
only from situations where IDC's show a hyperplastic response as discussed
above, but also in Histiocytosis X.

Histiocytosis X is now considered

as a Langerhans cell granulomatosis (Wolff, 1972), since the prominent
atypical cell is a type of Langerhans cell as gauged by identification of
ultrastructural Birbeck granules and the presence of T6 antigen (Murphy,
1981,

Harrist, 1983).

Such cells are also S-100-positive in contrast to
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other histiocytic disorders of the skin such as juvenile xanthogranulomas
and reticulohistiocytomas where histiocytes and giant cells predominate
(Rowden et al., 1983).
Langerhans Cell Roles
It seems unlikely that Langerhans cells function as active phagocytes in the epidermis or oral epithelium.

It has been demonstrated that

the surrounding keratinocytes in epithelium have the ability to phagocytose many times more vigorously than Langerhans cells (Wolff, 1970).

As

such the ability of the keratinocyte to phagocytose is not surprising
since this process is an essential step in pigment processing.

What is

surprising is that Langerhans cells if they are to be considered members
of the MPS (macrophage phagocyte system) should perform this function so
poorly.

There seems to be little similarity between the miniscule phago-

cytic activity of the Langerhans cell and the tremendous phagocytic capacity of the traditional macrophage.
Langerhans celJs have been shown to express T6 antigen, a glycoprotein not normally associated with conventional macrophages (Murphy et
al., 1981).

This most recent finding is a further method of discriminat-

ing between dendritic cells and macrophages.

What is not known is wheth-

er they represent distinct lineages or are related by functional activation of a stage in the cell cycle.
Langerhans cells have many attributes which suit them for participation in a number of immunologic reactions.

They assume a strategic

position in the epidermis and the epithelium of the oral mucosa.
was confirmed for oral mucosa.

This

They have been referred to as the 11 the
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body's first line of immunologic defense 11

(Silberberg et al., 1975).

Langerhans cells have also been shown to possess up to twelve dendrites,
each of these with an immunologically reactive terminal portion (Cruickshank, 1975).

This physical attribute gives the Langerhans cell a tre-

mendously increased surface area which would enhance its capacity for
immune surveilance.

There are other factors which when considered tend

to point more toward Langerhans cell participation in immunologic reactions.

In a very short period of time Langerhans cell will present at

the site of antigenic challenge (Silberberg et al., 1975).

The same

group demonstrated that Langerhans cells are a dynamic migrating cell
population rather than fixed cells in the epidermis (Silberberg et al.,
1975).
The role.of Langerhans cells in the pathogenesis of periodontitis
is not known.

However, other studies suggest such a pathway.

Shelley

and Juhlin (1976) demonstrated in guinea pigs and humans the selective
uptake by langerhans cells of small molecules (metals, aldehydes, amines)
which have been known to act as contact allergens.

They postulated that

Langerhans cells formed a reticuloepithelial trap indicating a close relationship to the reticuloendothelial system which clears the tissue of
antigens in the general circulation.
that of the lymph node and spleen.

This may in fact be analogous to
It appears that haptens or antigens

which are able to penetrate the stratum corneum into the avascular epidermis are then trapped by the 11 protective reticulum 11 of langerhans cells
(Shelley and Juhlin, 1976).

Furthermore, the presence of !a-antigens on

the surface of such dendritic cells may be explained because of the
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importance of genetic restriction in such antigens between antigen-presenting cells and responding lymphocytes.
erally phagocytose larger molecules.
patable with the

sugge~ted

Conventional macrophages gen-

These observations would be com-

function of Langerhans cells in periodontitis.

Langerhans cells are particularly well suited to be the first line of
immunologic defense in the skin and chronic antigenic stimulation of the
oral mucosa.

Antigenic presentation rather than phagocytosis seems to be

the major functional role the Langerhans cell plays in these reactions.
Langerhans Cells in Contact Dermatitis and Periodontitis
There is good evidence that Langerhans cells play an important role
in allergic contact dermatitis of skin.

Langerhans cells have been iden-

tified in close apposition (peripolesis) to mononuclear cells in the
epidermis at sites of contact allergic hypersensitivity reactions (Silberberg 1976A).

Apposition of Langerhans cells to mononuclear lymphocyte-

like cells was not observed at sites of contact primary irritant reactions.
Two to three hours after antigenic challenge with known contact allergens
an increase in Langerhans cells in the dermis was noted (Silberberg 1973,
1975).

Langerhans cells have been identified in the dermal lymphatics

and in the draining lymph nodes subsequently after trapping antigens in
the skin (Silberberg, 1976).
Although there appears to be a constant migration of Langerhans
cells to lymph nodes in presumably nonreactive skin, the migration of
both Langerhans cells and indeterminate dendri.tic cells (Ioc•s) from skin
via dermal lymphatics to draining lymph nodes is much more readily seen
at the site of challenge after topical or intradermal challenge of
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antigen in sensitized guinea pigs than in normal control animals.

This

migration is multiplied by a factor of 3 to 7 in immunologically reactive
skin (Silberberg-Sinakin and Thorbecke 1980).
Langerhans cells may have secretory functions involved in the contact hypersensitivity reactions (in which they have been described) Silberberg, 1973, Silberberg-Sinakin, 1976, Silberberg, 1975).

A possible

secretory function in regards to Langerhans cells function is related to
the prostaglandin activity at sites of contact dermatitis and has been
postulated.

This activity is due to prostaglandins E and F (Goldyne et

al., 1973, Greaves et al., 1971).

The major portion of prostaglandin

activity appears to be in the epidermis rather than in the dermis (Jouvenaz et al., 1970, Dorp et al., 1971).

The mononuclear phagocyte has

been suggested as the principal hemopoietic cell source of prostaglandin
E (Kurland et al., 1977, Brune et al., 1978).

The formation of vacuoles

in macrophages, resembling those seen in Langerhans cells is reported to
coincide with prostaglandin formation and has been postulated to be the
end result of the fusion of different cell organelles and the ensuing
increased contact of the enzymes with their respective substrates (Bruen
et al, 1978).

Therefore if Langerhans cells represent the mononuclear

phagocyte system in the epidermis, they are likely to be an important
source of prostaglandins in the skin.(Silberberg-Sirakin and Thorbecke,
1980).
There is evidence that activated macrophages are the major source
of prostaglandins in diseased gingiva (Loning 1980).

Little support has,

however, been given to the prostaglandin activity of the Langerhans cell

48

and this area is clearly in need of further investigation.
In the present study increased number of Langerhans cells were
shown to be present in the inflamed oral epithelium associated with periodontitis.

This was compared to clinically normal epithelium which was

treated by removal of bacteria laden calculus.

The increased number of

Langerhans cells in periodontitis suggests that there may be an immunologic response to plaque antigens.
Bos and Burkhardt (1980) demonstrated that when germ free mice developed an oral flora there was a concomitant increase in epithelial
Langerhans cells.

Newcomb et al., 1982 reported in four patients that as

plaque accumulated there was a statistically significant increase in
Langerhans cells in the oral epithelium.

The results of these studies

demonstrated a response of oral epithelial Langerhans cells elicited upon
antigenic stimulation and agree with the results of the present study.
Keratinized oral epithelium such as that found in gingiva has been
considered relatively impermeable to ingress of foreign antigens.

How-

ever, certain dyes (Adams 1975) and radio-labelled substances (Haugen and
Johansen 1975) have been shown to rapidly penetrate well into keratinized
epithelium.

It has been generally accepted that bacterial plaque anti-

gens which accumulate on the tooth surface or directly on oral epithelium
can also penetrate this tissue and elicit a host response.

As the Langer-

hans cell has been shown to increase in numbers with an increased bacterial antigenic challenge and may play an integral role in the host response, suggests that they function in the pathogenesis of periodontitis.
In the present study, Langerhans cells were identified in the
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lamina propria with all techniques utilized with the exception of ATPase
due to staining of blood vessels and background staining.

It was not

determined if these cells were migrating towards the epithelium or back
to regional lymph nodes carrying antigenic information.

Although there

appears to be a constant migration of Langerhans cells to lymph nodes in
presumably nonreactive skin, the migration of both Langerhans cells and
indeterminate dendritic cells (IDC's) from skin via dermal lymphatics to
draining lymph nodes is much more readily seen at the site of challenge
after topical or intradermal challenge of antigen in sensitized guinea
pigs than in normal control animals.

This migration is multiplied by a

factor of 3 to 7 in immunologically reactive skin.

Langerhans cells car-

rying antigen have been seen in dermal lymphatics as early as 2 hours
after challenge.

(Silberberg-Sinakin and Thorbecke, 1980).

The increase in Langerhans cell numbers in this study seems to be
a result of migration from the connective tissue into the epithelium.
Kinetic investigations of Langerhans cells have shown that a very small
number of cells are capable of proliferation within the epidermis.
number may be as low as 2% (Gschnait and Brenner 1979).

This

In the absence

of overt pathology it is generally agreed that only molecules of low
molecular weight may pass through skin.

It is also generally agreed

upon among periodontists that plaque bacteria do not penetrate the tissues during chronic periodontal disease processes.

While bacteria have

been reported in the gingiva, this occurrence is considered to be rare.
Bacteria have been observed in gingival tissues associated with chronic
periodontitis (Michel, 1969, Frank, 1972, Frank and Vogel, 1978) and in
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juvenile periodontitis (Gillette and Johnson, 1982).

However, the sub-

sequent host immunologic activity most likely is in response to antigens
or haptens of bacterial plaque origin including enzymes and components
of the bacterial cell structure.

Currently, reports suggest that the

Langerhans cell may play a role in processing foreign mo1ecu1es as previously discussed.
In the present study Langerhans cells were significantly shown to
be present in increased numbers in clinically inflamed gingival epithelium when compared to clinically normal oral epithelium.

In oral mucosa,

it is not probable normally to develop sensitivity to a particular antigenic challenge; in fact one will develop tolerance.

This is in contrast

to the results of studies in allergic contact hypersensitivity of the
skin.

It is not sensible to explain these differences in host response

in terms of different populations of cells.

Rather, in the oral environ-

ment these antigenic processing cells of the epithelium are laregly
evaded because of the binding, cleansing and actual physical "sweeping
away" by salivary glycoproteins as well as the various enzymatic reactions
in these secretions to which antigens are subjected.

These antigens are,

however, carried into the gastrointestinal system where a supressor mechanism is triggered.
In the case of chronic stimulation as produced when densely bacterial laden calculus attaches to a tooth surface, a strong host immunologic reaction may develop.

In this situation the antigenic stimulation

on contact with mucosa is present long enough due to the plaque and calculus density representing a depot effect as opposed to being washed
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away by the physical actions of saliva.

The chronic inflammation which

ensues and the development of sensitivity to specific bacteria may be
amplified when host defense mechanisms are altered.

Studies have shown

both T and B cells react to antigenic challenge by blast transformation,
lymphokine production, and antibody production.

Also, circulating anti-

bodies specific for plaque organisms have been reported.

Such observa-

tions support the concept of an immune response mechanism in periodontitis.
If bacterial products (i.e., endotoxin) gains access to oral tissues and presentation of the antigens by Langerhans cells takes place,
there would be sensitization as opposed to suppression.

In chronic peri-

odontal disease states there is a depot effect of potential bacterial
antigens.

This has been documented as a transitional constantly changing

bacterial flora (Listgarten and Hellen, 1978).

The flora of chronic

periodontal disease states has been documented as changing from a relatively innocous G.ram+ nonmotile predominated to a destructive Grammotile dominated situation.

As the relative numbers of Gram- motile or-

ganisms increases along with increasing numbers of other potentially
antigenic substances of the Gram- bacterial cell wall (i.e., endotoxin),
the immunologic

challeng~

is multiplied accordingly.

The increase in the numbers of Langerhans cells identified in clinically inflamed gingival tissues associated with periodontal disease in
the present study may be in response to this increased immunologic challenge.

This suggests that Langerhans cells are functional in the presen-

tation of bacterial plaque antigens to T lymphocytes.

The T lymphocytes

then proliferate in a response to the specific bacterial plaque antigens
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producing lymphokines and to help B cells to produce specific circulating
antibodies directed against the antigens.

This more significant role

postulated for the Langerhans cell is compatible with what we now know
about the host response in chronic periodontal disease.
The objectives of the present study were to determine which of the
staining techniques if any were superior for the identification of Langerhans cells in human oral mucosa.

It was determined that OKT-6 was qual-

itatively the best technique studied for this purpose.

Another objective

was to determine if there was a difference in the numbers of Langerhans
cells present in chronically inflamed human gingiva associated with periodontitis and clinically normal tissue.

Langerhans cells were shown to

be significantly increased in the chronically inflamed tissues associated
with periodontal disease and were found in numbers averaging as many as
five times that found in clinically normal tissue.

CHAPTER VI
SU~~ARY

AND CONCLUSIONS

In the present study, eleven patients were selected who presented
with chronic periodontitis and displayed moderate to severe gingival inflammation as assessed by the G.I. of Loe (1967).

A sextant associated

with clinically inflamed tissues was not treated, while the remaining
teeth were scaled and root planed.

Two gingival biopsies were taken;

clinically normal treated, and clinically inflamed untreated tissue.
Langerhans cells cannot be identified by H&E stained sections.

Histo-

chemical and immunocytochemical methods were used for staining and
slides were examined under light microscopy.
In the present study Langerhans cells were specifically stained
for ATPase (Wachstein and Meisel, 1957), HLA-DR (Rowden, 1977), S-100
Cocchia et al; 1981), and OKT6 (Murphy, 1982).

Langerhans cells were

quantitated using standardized grids in OKT6 stained sections.

Approx-

imately five times as many Langerhans cells were identified in the
standardized sections of clinically inflamed human gingiva as in clinically normal gingiva of the same patient.

This was shown to be a

statistically significant increase (P = .01).
All special stains tested were effective to some degree in demonstrating Langerhans cells in human gingival epithelium.

Of the methods

studied, OKT6 (Murphy, 1982) was qualitatively determined to be the
53
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best technique for visualization of Langerhans cells under light microscopy.

This technique would be recommended for future investigations

concerning Langerhans cells in oral mucosa.

The results also suggest

that Langerhans cells may respond in chronic periodontitis by increasing
in numbers possibly in response to dental plaque antigens. An immunologic role in the host response to chronic periodontal disease is postulated for Langerhans cells.
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APPENDIX
TABLE 1 -Specimen #1 Clinically Normal
Nuclei of Epithelial Langerhans Cells Identified in Each·
0.13 mm 2 Microscopic Field - 43 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)
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APPENDIX
TABLE 2 - Specimen #1 Clinically Inflamed
Nuclei of Epithelial Langerhans Cells Identified in Each
0.13 mm 2 Microscopic Field - 50 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)
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TABLE 3 - Specimen #2 Clinically Normal
Nuclei of Epithelial Langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field - 60 Fields Examined
{Section Prepared by OKT-6 Technique and Observed at 400X)
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TABLE 4 - Specimen #2 Clinically Inflamed
Nuclei of Epithelial langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field - 60 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)
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TABLE 5 - Specimen #3 Clinically Normal
Nuclei of Epithelial Langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field - 36 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)
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TABLE 6 - Specimen #3 Clinically Inflamed
Nuclei of Epithelial Langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field - 52 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)
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TABLE 7 - Specimen #4 Clinically Normal
Nuclei of Epithelial Langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field - 56 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)
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1

0

0

0

0

1

0

0

0

0

1

'
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APPENDIX
TABLE 8 - Specimen #4 Clinically Inflamed
Nuclei of Epithelial Langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field- 56 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)

0

0

0

1

2

2

0

0

0

1

2

2

0

0

1

1

2

2

0

0

1

1

2

2

0

0

1

1

2

2

0

0

1

1

2

2

0

0

1

1

2

0

0

1

1

2

0

0

1

1

2

0

0

1

1

2

..
'
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APPENDIX
TABLE 9 - Specimen #5 Clinically Normal
Nuclei of Epithelial Langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field - 28 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

.. 1

0

0

0

0

0

0

0

0

0

'

1
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APPENDIX
TABLE 10 - Specimen #5 Clinically Inflamed
Nuclei of Epithelial Langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field - 28 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)

0

0

1

0

0

1

0

0

1

0

0

1

0

1

2

0

1

2

0

1

2

0

1

2

0

1

0

1
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APPENDIX
TABLE 11 - Specimen #6 Clinically Normal
Nuclei of Epithelial Langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field- 46 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)

0

0

0

0

1

0

0

0

0

1

0

0

0

0

1

0

0

0

0

1

0

0

0

0

1

0

0

.o

0

1

~

'

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1
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APPENDIX
TABLE 12 - Specimen #6 Clinically Inflamed
Nuclei of Epithelial Langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field - 28 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400)

0

0

1

0

0

1

0

0

2

0

0

2

0

1

2

0

1

"2
'

0

1

2

0

1

2

0

1

0

1

80
APPENDIX
TABLE 13 - Specimen #7 Clinically Normal
Nuclei of Epithelial Langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field - 28 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)

0

0

1

0

0

1

0

0

1

0

0

1

0

0

1

0

0

2

0

0

2

0

0

2

0

0

0

1
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APPENDIX
TABLE 14 - Specimen #7 Clinically Inflamed
Nuclei of Epithelial Langerhans Cells Identified in
Each 0.13 mm 2 Microscopic Field - 42 Fields Examined
(Section Prepared by OKT-6 Technique and Observed at 400X)

0

1

2

2

0

1

2

2

0

1

2

2

0

1

2

2

0

1

2

2

0

1

..,2

2

0

1

0

'

2

3

1

2

3

0

1

2

3

1

2

2

3

3
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APPENDIX
TABLE 15 - Nuclei of Epithelial Langerhans Cells Anticipated
in 1.0 mm 2 Microscopic Fields Prepared by the
OKT-6 Technique and Observed at 400X
Number of Langerhans Cell/ 1 mm 2
Specimen

Clinicalty Normal

Clinically Inflamed

1

1.3

7.5

2

2.5

8.7

3

3.0

5.5

4

3.0

9.8

5

1.8

6.25

6

0.5~

4.5

7

1,0

5.0
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Figure 1.

Hematoxylin and Eosin (Clinically Normal) 2.5X
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Figure 2.
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Hematoxylin and Eosin (Clinically Normal) lOX
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Figure 3.

Hematoxylin and Eosin (Clinically Inflamed) 2.5X
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Figure 4.

Hematoxylin and Eosin (Clinically Inflamed) lOX
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Figure 5.

ATPase (Robins and Brandon, 1981)
(Clinically Inflamed) 25X
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Figure 6.

ATPase (Robins and Brandon, 1981)
(Clinically Inflamed) 250X

89

Figure 7.

ATPase (Wachstein and Meisel, 1960)
(Clinically Normal) 2.5X
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Figure 8.

ATPase (Wachstein and Meisel, 1960)
(Clinically Inflamed) 2.5X
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Figure 9.

S-100 Protein (Clinically Normal) 2.5X
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Figure 10.

S-100 Protein (Clinically Inflamed) 2.5X
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Figure 11.

S-100 Protein (Clinically Inflamed) 250X

94

'

Figure 12.

HLA-DR (Clinically Normal) lOX
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Figure 13.

HLA-DR (Clinically Inflamed) lOX
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Figure 14.

HLA-DR (Clinically Inflamed) 25X

97

Figure 15.

HLA-DR (Clinically Inflamed) 25X
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'

•

•

Fig ure 16.

OKT-6 (Clinically Normal) 2.5X
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Figure 17.

OKT-6 (Clinically Inflamed) 2.5X
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Figure 18.

OKT-6 (Clinically Inflamed) 25X
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Figure 19.

OKT-6 (Clinically Inflamed) 400X
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Figure 20.

OKT-6 (Clinically Inflamed) 400X
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Fig. 21

Major Developments in the History of the Langerhans Cell

1868

Langerhans cell discovered by Paul Langerhans - thought of as
part of the nervous system

1961

electron microscopic features described (Birbeck et al.)

1966-7

Langerhans cells demonstrated in the oral epithelium (Schroeder
and Theilade, Waterhouse and Squier)

1967

Langerhans cell membrane shown to contain adenosine triphosphatase (ATPase) (Wolf and Winkelmann)

1973

apposition (peripolesis) of lymphocytes to Langerhans cells
demonstrated and antigen presentation by Langerhans cells
suggested (Silberg)

1974

migration of Langerhans cells via dermal lymphatics to lymph
nodes described (Silberberg et al.)

1976

11

1977

cell membrane receptors for Fe fragment of IgG and complement
{Stingl et al) and Ia histocompatibility surface antigens
(Rowden et al., Klareskog et al., Stingl et al.)

1978

demonstration of initiation of immune response by Langerhans
cells (Stingl et al.)

1982

association between plaque accumulation and Langerhans cell
numbers in the oral epithelium of attached gingiva demonstrated
(Newcomb et al.)

reti cul o-epi the 1 i a1 trap 11 for contact a11 ergens suggested
(Shelley and Juhlin)

104

Fig. 22 Protocol for ATPase Preparation
(Wachstein and Meisel, 1960)

1.

Frozen sections cut at 10 microns

Air dry 15 minutes - DH 2o rinses 3 times
3. ATPase solution (low heat and stir while making solution)

2.

0.125% ATPase 20 ml
0.2 MpH 7.2 Tris

22 ml

1M Magnesium Sulfate 5 ml
2% Lead Nitrate 2.4 ml drop by drop, precipitate will occur
4.

Filter

5.

Preheat to 37°C
(if necessary filter again)

6.

Incubate in 37°C oven 60 minutes

7.

DH 2o rinse 5 times

8.

2% ammonium sulfide - (rinse under hood until developed)

9.

DH 20 rinse 5 times

10. Aquamount
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Fig. 23 Protocol for ATPase Preparation
(Robins and Brandon, 1981)
l.

2.

Fix at 0-4°C in cacodylate formalin for l hour
i .e. distilled water 50 ml

40% formaldyhyde

0.2 M cacodylic acid 40 ml

sucrose

10 ml
6.85

g

Rinse in Phosphate Buffered Saline (equal parts of 0.15 m
phosphate buffer and 0.85% saline)

3.

Freeze and store at -80°C

4.

Frozen sections cut with cryostat to 5

5.

Air dry several hours

6.

Incubate in sections in freshly prepared, prefiltered and prewarmed

~

- 10

~

sections

ATP substrate at 37°C for 120 minutes (Modified Juhlin and Shelley
(1977) substrate).
distilled water 50 ml
0.25 M trismaleate buffer 40 ml
pH 7.2
0.1 MMagnesium Sulfate 1- ml
glucose 5 g
adenosine-5-triphosphate 80 mg
2% Lead Nitrate 10 ml
pH of final solution to be 7.0
7.

Rinse in distilled water

8.

Develop in 1% ammonium sulfide until Langerhans Cells developed

9.

Rinse in tap water

10. Aquamount
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Fig. 24 Protocol for S-100 Self Sandwich Preparation
(Hsu, 1981)
1. Mount 4 pro paraffin sections on prepared glued slides and dry at
56°C
2.

Deparaffinize in 3 changes of xylene

3.

Hydrate through graded alcohols to distilled water

4.

Trypsinize 0.001 gm trypsin, 1 ml. 0.1% Cacl 2 15 minutes
Phosphate Buffered Saline Rinse
(equal parts of 0.15 Mphosphate buffer and 0.85% saline)

6.

Block endogenous with 3% H2o2 10 minutes
PBS
Block endogenous with 1-5 normal swine serum

7.

Incubate S-100 AB (1-20)

8.

Incubate S-100 Ag 30 minutes

5.

30 minutes

Rinse

PBS wash

~

9.

(10 lambda S-100 Antigen - 1 ml PBS)

PBS Wash

Incubate S-100 AB (1-20)

PBS Wash

30 minutes

10.

Incubate swine anti-rabbit (1-20)

11.

Incubate rabbit peroxidase antiperoxidase (1-100) 30 minutes PBS Wash

12.

Develop sites with 3,9 amino ethyl carbazole

13.

Counterstain with Mayers hematoxylin

14.

Blue with saturated lithium carbonate

15. Aquamount

30 minutes

PBS Wash

H2o wash
H20 Wash
H2o Wash
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Fig. 25

Protocols for OKT-6 and HLA-DR Preparation
(Murphy, 1981)

1.

Frozen section cut at 10 microns- air dry

2.

Fix in cold acetone - 30 minutes
PBS Wash

3.

Incubate with monoclonal HLA-DR (Becton Dickinson)/ODT-6 (Ortho
Diagnostic

4.

PBS Wash

Incubate with rabbit antimouse peroxidase conjugated (1-10)
60 minutes

5.

60 minutes

PBS Wash

Develop sites with 3,9 - amino ethyl carbazole
H2o Wash
This step is performed qualitatively and the slide is examined
under a microscope for the presence of Langerhans cells

6.

Counterstain with Mayers hematoxylin
H20 Wash

7. Blue with saturated lithium carbonate
H2o Wash
8. Aquamount
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Fig. 26 Criteria for the Gingival Index System

0 = Normal Gingiva
1 = Mild inflammation - slight change in color, slight edema.
No bleeding on probing.
2 =Moderate inflammation- redness, edema and glazing.
Bleeding on probing.
3 = Severe inflammation - marked redness and edema, ulceration.
Tendency to spontaneous bleeding.
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Fig. 27 Statistical Analysis

MEAN

ST. DEV.

T test

1N
1I

0.19048
1.200

0.397
1.00

T = -4.826
T test significant at 0.01

2N
21

0.33333
1.3864

0.488
1.06

T= -5.171
T test significant at 0.01

3N
31

0.500
0.84615

0.798
0.881

T = -1.203
Cannot reject T at 0.05

4N
41

0.26786
0.89286

0.522
0.824

T = -4.794
T test significant at 0.01

5N
51

0.071429
0.64286

0.267
0.745

6N
61

0.12500
0.71429

0.334
0.810

T = -3.696
T test significant at 0.01

7N
71

0.42857
1.4390

0.690
0.976

T = 5.037
T test significant at 0.01

..
'

T = -2.702
T test significant at 0.01
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Fig. 28 PROCEDURE

Gingival sulcus excised
during periodontal surgery

Transported in RPMI culture medium
to medical school lab

~

Divided into 3 sections
under dissecting microscope

Fixed in buffered
formalin for 8 hours
at room temperature

Fixed in Formaldehydecacodylate solution
for 1 hr. at 0-4°C

Buffer

Wash
phosphate buffered saline

Paraffin embedded
for H & E stain and
S-100

Freeze and store
-80°C
ATPase
staining

Freeze in
isopentane liquid
nitrogen
HLA-DR
and
OKT 6
staining
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Fig. 29

Letter to Institutional Review Board Chairman

LOYOLA UNIVERSITY
OF CHICAGO

2160 S. FIRST A'/ENUE
MAYWOOD. IL 60153

SCHOOL OF DENTISTRY

A

Qwuw

oTSeru1ce
July 13, 1982
Dr. Silvio Aladjem
Obstetrics and Gynecology
Loyola University
2160 S. First Avenue
Dear Dr. Aladjem:
I would like to begfn a research project in the department of
Periodontics here at Loyola University School of Dentistry. I will be
examining sections of human gingiva obtained during surgery for the
presence of Langerhans cells. I will be using for my study, specimens
of human gingiva which have been removed as part of the periodontal
surgical procedures used in the routine treatment of periodontal disease.
The patients will be required to sign the attached consent form
as do all patients who have periodontal surgery performed here. I have
added one sentence to be more specific towards my research.
These tissues are commonly stained by many techniques as will be
done in my study. I therefore would like to request an expedited review
since there is minimal risk to the patient, the surgical procedures will
not be altered in any way from that normally used, and the procedure has
been used previously in other research projects.
·
Respectfully,

Charles DiFranco, D.D.S.
Dept. of Periodontics

112

Fig. 30 Reply from Institutional Review
Board Chairman

LOYOLA UNIVEHSITY i\IEIJlCAI., CENTEH
2160 Suuth fo·iut Avconue. MO\Y\\'C>('Od, lllinni:c fi015.1

312

5l1·3000

July 14, 1982
Charles DiFranco, D.D.S.
Department of Periodontics
Dental School
Loyola University School of Dentistry
Dear Dr. DiFranco:
In reply to your letter of July 13, 1982, as long as the
specimen is obtained during a surgical procedure which the
patient undergoes for reasons unrelated to your study, and
as long as the specimen is not identified in terms of a
patient's name, there is no need for IRB submission.
This
falls under the category of studies of pathologic tissue.
There is no need to !nclude the added underlined sentence
in the consent form.
It should also be clear that the cost
of your study should not be billed to the patient.
Thank you for consulting the Board in this matter.
(

Sin<<<oly, \

lvi~~j l':~\~ni

Si
<nnn
'
\
Institutlonal Revie~ Board for the
Protectio'n of Human ~ubjects - Hedical Center
SA/s
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Fig. 31 CONSENT AND PERMIT FOR PERIODONTAL SURGERY

Patient
Place:

Age_ _ _ __
Loyola University
School of Dentistry
May1~ood, I 11 i noi s

Date_ _ _ __
Time_ _ _ __

1.

Thereby consent, authorize and r~quest· the Department of Periodontics, Loyola
University, Haywood, Illinois to perform periodontal surgery and all other
necessary therapeutic surgical procedures, which have been prescribed to me.

2.

I also consent, authorize and request the administration of such anesthetic
or medication as may be deemed advisable for the procedure. The nature, purpose
and risk of the anesthetic or medications and possible alternative methods of
anesthesia and medication have been explained to me. I acknowledge that no
guarantee or assurance has been made as to the results of said anesthetics
or medications.

3.

If any unforseen condition ari1ses in the course of this procedure calling in
the judgement of the therapist for surgical or nonsurgical procedures in
addition to those now contemplated, I further request and authorize him to
do whatever he deems advisable and necessary in the circumstances.

4.

I have been informed that periodontal surgery is intended to extend the length
of tooth retention and that no prognosis can be designated to each tooth and
that teeth having a questionable prognosis may require extraction after a
surgical evaluation.

5.

I am aware of the aesthetic ·appearance (gingival recession with root exposure)
which may be necessary in order to obtain a good periodontal result.

6.

I have been informed of possible post periodontal root sensitivity.

7.

It has been explained that I must maintain diligent and consistent home care,
obtain frequent cleanings and proper oral rehabilitation in order to increase
tooth longevity.

8.

The nature and purpose of the procedure and possible alternative methods of
treatment, have been explained to me. Further, I consent to the disposal of
any tissue which may be removed unless otherwise requested by me to be
examined by a pathologist. I consent to having any tissues which may be
removed to be examined for the presence of Langerhans cells.

9.

If the patient is under 18 years of age, his or her parent or guardian must
sign below and thereby accept and agree to the foregoing on behalf of
himself or herself and his child or ward.

The above has been read and understood by me.
content.

I accept responsibility for said

(Resident or Attending Dentist)

\Patient or Guardian)
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